SERPINC1 and cancer: Reports on AT-III in this regard are relatively scarce, the existing evidence indicates that AT-III exerts more limited anti-proliferative effects in vitro compared to AT-I and AT-II, with reported IC50 values often exceeding 100 μM in various cancer cell lines [66,67].